CS

Craig A. Smith

IM Immunex: 25 patents #10 of 178Top 6%
CA Cardiogenesis: 3 patents #6 of 17Top 40%
GL Glaxosmithkline Australia Pty Limited: 2 patents #1 of 12Top 9%
JL Johnson Matthey Public Limited: 2 patents #296 of 922Top 35%
ET Eclipse Surgical Technologies: 1 patents #32 of 53Top 65%
CU Columbia University: 1 patents #37 of 176Top 25%
TU Trustees Of Indiana University: 1 patents #114 of 337Top 35%
Overall (All Time): #103,748 of 4,157,543Top 3%
34
Patents All Time

Issued Patents All Time

Showing 25 most recent of 34 patents

Patent #TitleCo-InventorsDate
8377448 CD47 related compositions and methods for treating immunological diseases and disorders Steven R. Wiley, Ajamete Kaykas, Peter Probst 2013-02-19
8293500 Methods for identifying polypeptide targets and uses thereof for treating immunological diseases Steven R. Wiley, Ajamete Kaykas 2012-10-23
8106201 Process for the synthesis of morphinane compounds and intermediates thereof Stuart Purcell, Lucy Waddell, Nicholas Hayes, Jarrod Ritchie, Scott Brian Halliday +2 more 2012-01-31
7875718 Process for the synthesis of morphinane compounds and intermediates thereof Stuart Purcell, Lucy Waddell, Nicholas Hayes, Jarrod Ritchie, Scott Brian Halliday +2 more 2011-01-25
7459528 Glycoproteins which bind to TNF Raymond G. Goodwin, M. Patricia Beckmann 2008-12-02
7232660 CD30 ligand Raymond G. Goodwin, Richard J. Armitage 2007-06-19
7211259 4-1BB polypeptides and DNA encoding 4-1BB polypeptides Raymond G. Goodwin 2007-05-01
7138500 Antibodies to human 4-1BB Raymond G. Goodwin, Mark Alderson 2006-11-21
7057022 Antibodies which specifically bind to TNF-R Raymond G. Goodwin, M. Patricia Beckmann 2006-06-06
6852486 Viral proteins capable of binding LAR Raymond G. Goodwin 2005-02-08
6667039 CD30 ligand Raymond G. Goodwin, Richard J. Armitage, Hans-Juergen Gruss 2003-12-23
6572852 Method for suppressing inflammatory responses by administering TNFR Raymond G. Goodwin, M. Patricia Beckmann 2003-06-03
6541610 Fusion proteins comprising tumor necrosis factor receptor 2003-04-01
6524298 Therapeutic and diagnostic agent delivery Keith L. March, Michael Aita, Randy J. Kesten 2003-02-25
6355779 Cytokine designated 4-1BB ligand antibodies and human receptor that binds thereto Raymond G. Goodwin, Mark Alderson 2002-03-12
6224584 Therapeutic and diagnostic agent delivery Keith L. March, Michael Aita, Randy J. Kesten 2001-05-01
6201105 Tumor necrosis factor receptor polypeptides recombinant P75 (Type II) Raymond G. Goodwin, M. Patricia Beckmann 2001-03-13
6143869 CD30 ligand oligomers and polypeptides Raymond G. Goodwin, Richard J. Armitage, Hans-Juergen Gruss 2000-11-07
RE36755 DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors Raymond G. Goodwin, M. Patricia Beckmann 2000-06-27
5997525 Therapeutic and diagnostic agent delivery Keith L. March, Michael Aita, Randy J. Kesten 1999-12-07
5945397 Purified p75 (type II) tumor necrosis factor receptor polypeptides Raymond G. Goodwin, M. Patricia Beckmann 1999-08-31
5871740 Methods of using poxvirus p35 as a chemokine inhibitor and compositions therefore 1999-02-16
5840059 Therapeutic and diagnostic agent delivery Keith L. March, Michael Aita, Randy J. Kesten 1998-11-24
5753203 CD30 ligand conjugates Raymond G. Goodwin, Richard J. Armitage, Hans-Juergen Gruss 1998-05-19
5712155 DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors Raymond G. Goodwin, M. Patricia Beckmann 1998-01-27